SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: drkaz who wrote (12749)5/12/2020 1:07:44 PM
From: mattstat  Read Replies (1) | Respond to of 12871
 
More diversions Kaz. God forbid, they actually have to prove any of this stuff works. Better to keep the sheep guessing and hoping. The truth may just put an end to the party for Diwan.



To: drkaz who wrote (12749)5/12/2020 9:09:17 PM
From: HardToFind  Respond to of 12871
 
Not a bad thing in itself - but - again - what about the shingles application?
Maybe management sees this as a quicker path to much-needed working capital.

Do you know what they're working on (the next deliverable) for HerpeCide? I forget...Do we have any formal toxicology studies back for the herpes drug candidates?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News